U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07404605) titled 'Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous Melanoma' on Feb. 04.
Brief Summary: Cutaneous melanoma frequently develops cutaneous and subcutaneous metastases, which may cause significant morbidity and negatively affect quality of life. Electrochemotherapy (ECT) is an established local treatment modality for cutaneous and subcutaneous tumor lesions that combines the administration of cytotoxic drugs with the application of electric pulses to increase drug uptake into tumor cells.
In addition to its direct cytotoxic effects, electrochemotherapy may induce changes in the tumor microenvironment, including...